Dashboard
Manage Tickers

MBIOMUSTANG BIO, INC.

Nasdaq mustangbio.com


$ 0.32 $ 0.01 (3.97 %)    

Friday, 17-May-2024 15:48:19 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 451.63 $ -0.22 (-0.05 %)
DIA $ 399.76 $ 0.74 (0.19 %)
SPY $ 529.24 $ 0.76 (0.14 %)
TLT $ 91.40 $ -0.62 (-0.67 %)
GLD $ 223.63 $ 3.63 (1.65 %)
$ 0.312
$ 0.31
$ 0.00 x 0
$ 0.00 x 0
$ 0.31 - $ 0.33
$ 0.22 - $ 8.17
178,666
na
3.51M
$ 1.57
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 03-11-2024 12-31-2023 10-K
3 11-14-2023 09-30-2023 10-Q
4 08-14-2023 06-30-2023 10-Q
5 05-12-2023 03-31-2023 10-Q
6 03-30-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-12-2022 03-31-2022 10-Q
10 03-23-2022 12-31-2021 10-K
11 11-12-2021 09-30-2021 10-Q
12 08-16-2021 06-30-2021 10-Q
13 05-14-2021 03-31-2021 10-Q
14 03-24-2021 12-31-2020 10-K
15 11-06-2020 09-30-2020 10-Q
16 08-10-2020 06-30-2020 10-Q
17 05-11-2020 03-31-2020 10-Q
18 03-16-2020 12-31-2019 10-K
19 11-12-2019 09-30-2019 10-Q
20 08-09-2019 06-30-2019 10-Q
21 05-10-2019 03-31-2019 10-Q
22 03-18-2019 12-31-2018 10-K
23 11-13-2018 09-30-2018 10-Q
24 08-13-2018 06-30-2018 10-Q
25 05-14-2018 03-31-2018 10-Q
26 03-29-2018 12-31-2017 10-K
27 11-14-2017 09-30-2017 10-Q
28 08-14-2017 06-30-2017 10-Q
29 05-15-2017 03-31-2017 10-Q
30 03-31-2017 12-31-2016 10-K
31 11-14-2016 09-30-2016 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-buy-on-mustang-bio-maintains-2-price-target
HC Wainwright & Co. Reiterates Buy on Must...
05/16/2024 15:33:56

HC Wainwright & Co. analyst Joseph Pantginis reiterates Mustang Bio (NASDAQ:MBIO) with a Buy and maintains $2 price target.

hc-wainwright--co-maintains-buy-on-mustang-bio-adjusts-price-target-to-2
HC Wainwright & Co. Maintains Buy on Musta...
05/13/2024 16:29:06

HC Wainwright & Co. analyst Joseph Pantginis maintains Mustang Bio (NASDAQ:MBIO) with a Buy, adjusts target to $2 from $25.

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
05/03/2024 20:31:06

reported-earlier-mustang-bio-prices-4m-public-offering-of-16877638-shares-of-common-stock-at-0237share
Reported Earlier, Mustang Bio Prices $4M P...
04/30/2024 08:21:34

Mustang Bio announced the pricing of a public offering of an aggregate of 16,877,638 shares of its common stock (or common stoc...

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
04/29/2024 20:31:14

mustang-bio-files-for-offering-of-up-to-156m-shares-of-common-stock-together-with-accompanying-warrants
Mustang Bio Files For Offering Of Up To 15...
04/29/2024 13:32:33

-SEC Filing

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
04/18/2024 20:31:32

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
04/18/2024 12:09:32

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
04/17/2024 20:31:15

mustang-bio-inc-approved-a-reduction-of-its-workforce-by-81-of-its-employee-base-workforce-reduction-will-take-place-primarily-in-april-2024-expected-to-be-substantially-completed-in-q2-of-2024-continue-to-evaluate-all-strategic-and-other-alternatives-related-to-business
Mustang Bio Inc Approved A Reduction Of It...
04/12/2024 20:21:01

- SEC Filing

mustang-bio-expands-car-t-cell-therapy-platform-expansion-into-autoimmune-diseases
Mustang Bio Expands CAR T-Cell Therapy Pla...
03/28/2024 13:03:27

Planning for proof-of concept Phase 1 investigator-sponsored clinical trial evaluating MB-106 CD20-targeted CAR T-cell therapy ...

mustang-bio-reports-fy23-eps-of-600-vs-1009-yoy-and-recent-corporate-highlights
Mustang Bio Reports FY23 EPS Of $(6.00) Vs...
03/11/2024 20:24:55

Financial Results: As of December 31, 2023, Mustang's cash and cash equivalents and restricted cash totaled $7.0 million...

why-rush-street-interactive-shares-are-trading-higher-by-around-25-here-are-20-stocks-moving-premarket
Why Rush Street Interactive Shares Are Tra...
03/07/2024 13:05:46

Shares of Rush Street Interactive, Inc. (NYSE: RSI) rose sharply in today’s pre-market trading as the company reported better...

Core News & Articles
Phase 1 CAR T Cell Therapy Trial For Gliob...
03/07/2024 10:06:54

Half of the enrolled patients had stable disease for at least two months, two showed partial response and two experienced com...

mustang-bio-presents-updated-phase-12-multicenter-clinical-data-for-mb-106-at-the-2023-ash-annual-meeting
Mustang Bio Presents Updated Phase 1/2 Mul...
12/11/2023 13:37:26

   Data showed favorable safety profile, complete response rate and durability in the treatment of patients with relapsed or re...

mustang-bio-q3-eps-123-misses-111-estimate
Mustang Bio Q3 EPS $(1.23) Misses $(1.11) ...
11/14/2023 22:06:44

Mustang Bio (NASDAQ:MBIO) reported quarterly losses of $(1.23) per share which missed the analyst consensus estimate of $(1.11)...

mustang-bio-announces-mb-106-cd20-targeted-car-t-data-selected-for-presentation-at-65th-ash-annual-meeting
Mustang Bio Announces MB-106 CD20-Targeted...
11/02/2023 13:29:29

why-harley-davidson-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Harley-Davidson Shares Are Trading Low...
10/26/2023 17:27:41

Gainers

mustang-bio-announces-44m-registered-direct-offering-of-2588236-of-its-shares-of-common-stock-at-a-price-of-170share-priced-at-the-market-under-nasdaq-rules
Mustang Bio Announces $4.4M Registered Dir...
10/26/2023 16:31:37

Mustang Bio, Inc. ("Mustang" or the "Company") (NASDAQ:MBIO), a clinical-stage biopharmaceutical company focuse...

mustang-bio-shares-are-trading-higher-after-the-company-announced-the-fda-accepted-its-ind-application-of-mb-109-for-the-treatment-of-recurrent-glioblastoma-and-high-grade-astrocytoma
Mustang Bio shares are trading higher afte...
10/26/2023 16:04:42

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION